1XFU | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) TRUNCATION MUTANT, EF-DELTA 64 IN COMPLEX WITH CALMODULIN |
1XFV | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND 3' DEOXY-ATP |
1XFW | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND 3'5' CYCLIC AMP (CAMP) |
1XFX | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN IN THE PRESENCE OF 10 MILLIMOLAR EXOGENOUSLY ADDED CALCIUM CHLORIDE |
1XFY | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN |
1XFZ | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN IN THE PRESENCE OF 1 MILLIMOLAR EXOGENOUSLY ADDED CALCIUM CHLORIDE |
1Y0V | F:64-277; F:64-277; F:64-277; F:64-277; F:64-277; F:64-277 | CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND PYROPHOSPHATE |
1PWP | B:553-775; B:553-775; B:553-775; B:553-775 | CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR COMPLEXED WITH SMALL MOLECULE INHIBITOR NSC 12155 |
1PWQ | B:553-775; B:553-775; B:553-775; B:553-775 | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH THIOACETYL-TYR-PRO-MET-AMIDE, A METAL-CHELATING PEPTIDYL SMALL MOLECULE INHIBITOR |
1PWU | B:553-775; B:553-775; B:553-775; B:553-775 | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH (3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE), A KNOWN SMALL MOLECULE INHIBITOR OF MATRIX METALLOPROTEASES. |
1PWV | B:553-775; B:553-775; B:553-775; B:553-775 | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR WILD-TYPE PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE. |
1PWW | B:553-775; B:553-775; B:553-775; B:553-775 | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR ACTIVE SITE MUTANT PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE IN THE PRESENCE OF ZINC. |
2L0R | A:2-105 | CONFORMATIONAL DYNAMICS OF THE ANTHRAX LETHAL FACTOR CATALYTIC CENTER |
3KWV | F:36-250; F:36-250 | STRUCTURAL BASIS FOR THE UNFOLDING OF ANTHRAX LETHAL FACTOR BY PROTECTIVE ANTIGEN OLIGOMERS |
1ZXV | B:553-775; B:553-775; B:553-775; B:553-775 | X-RAY CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR BOUND TO A SMALL MOLECULE INHIBITOR, BI-MFM3, 3-{5-[5-(4-CHLORO-PHENYL)-FURAN-2-YLMETHYLENE]-4-OXO-2-THIOXO-THIAZOLIDIN-3-YL}-PROPIONIC ACID. |